Blog

WM WM is benefiting from its robust infrastructure and extensive asset network in the waste removal services industry. A stable industry that provides essential services is driving WM’s sustainable

Johnson & Johnson's JNJ MedTech division, which spans orthopedics, surgery, cardiovascular and vision care, contributes roughly 36% to the company’s total revenues.

J&J is repositioning its MedTech

Microsoft MSFT has had a rough run in recent months, with its stock shedding 28.6% in the past six-month period, underperforming the Zacks Computer and Technology sector's decline of 7.9% as the

The market expects Neogen (NEOG) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook is

Simply Good Foods (SMPL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus

Wall Street expects a year-over-year decline in earnings on higher revenues when Byrna Technologies Inc. (BYRN) reports results for the quarter ended February 2026. While this widely-known

Roku Inc. ROKU shares have experienced significant volatility and a notable 12% year-to-date (YTD) decline, underperforming the broader Zacks Consumer Discretionary sector and the Zacks Broadcast

Here is a stock with buy rank and strong momentum characteristics for investors to consider today, April 2:

Flowco Holdings Inc. FLOC: This provider of production optimization, artificial lift and

Shares of NeuroPace, Inc. (NPCE) have gained 0.9% over the past four weeks to close the last trading session at $14.07, but there could still be a solid upside left in the stock if short-term price

Marex Group PLC (MRX) closed the last trading session at $43.05, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Aura Biosciences, Inc. (AURA) closed the last trading session at $6.7, gaining 8.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

vTv Therapeutics (VTVT) closed the last trading session at $40.53, gaining 12.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of Vor Biopharma Inc. (VOR) have gained 15.6% over the past four weeks to close the last trading session at $17.39, but there could still be a solid upside left in the stock if short-term

nCino (NCNO) closed the last trading session at $16.57, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Putnam Investments is one of the oldest U.S. asset managers, known for its mutual funds and retirement investment products. Founded in 1937 and based in Boston, the firm has a history of managing a

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates